Literature DB >> 25619805

Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.

Sharlene Gill1, Jean-Francois Haince2, Qian Shi3, Emily S Pavey3, Guillaume Beaudry2, Daniel J Sargent3, Yves Fradet2.   

Abstract

BACKGROUND: We aimed to clarify the prognostic value of guanylyl cyclase C (GCC) lymph node ratio (LNR) status as a predictor of recurrence in untreated stage IIA colon cancer on the basis of pooled individual data from previous studies.
METHODS: Patients were classified according to predefined GCC LNR risk groups (low, LNR ≤ 0.1; intermediate, 0.1 < LNR ≤ 0.2; high, LNR > 0.2). Outcomes included time to recurrence, disease-free survival, and overall survival. Stratified log-rank tests and multivariate Cox models assessed the association between outcomes and GCC lymph node status.
RESULTS: The final data set contained 553 patients with stage IIA colon cancer with a median of 18 lymph nodes examined after resection; 65 patients (11.8%) had recurrence. Overall, 109 patients (19.7%) were classified high risk on the basis of GCC LNR. In multivariate analysis, high GCC LNR value (> 0.2) was a significant predictor of cancer recurrence (hazard ratio [HR], 3.18; 95% confidence interval [CI], 1.77-5.71; P < .001) and lower disease-free survival (HR, 2.40; 95% CI, 1.60-3.62; P < .001) and overall survival (HR, 2.12; 95% CI, 1.35-3.33; P = .001).
CONCLUSION: Patients considered at high risk on the basis of their GCC LNR status have significantly inferior outcomes compared to those with low GCC LNR values, particularly among those traditionally considered to be at low risk for recurrence.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colon cancer; Guanylyl cyclase-C receptor; Lymph node ratio; Molecular staging; Prognosis

Mesh:

Substances:

Year:  2014        PMID: 25619805     DOI: 10.1016/j.clcc.2014.12.005

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  3 in total

1.  Role of CXC chemokine receptor type 7 in carcinogenesis and lymph node metastasis of colon cancer.

Authors:  Hong Xian Wang; Lin Yu Tao; K E Qi; Hao Yun Zhang; Duo Feng; Wen Jun Wei; Heng Kong; Tian Wen Chen; Qiu Sheng Lin; Dao Jin Chen
Journal:  Mol Clin Oncol       Date:  2015-09-15

2.  A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients.

Authors:  Ronald E Myers; Thomas Wolf; Phillip Shwae; Sarah Hegarty; Stephen C Peiper; Scott A Waldman
Journal:  BMC Cancer       Date:  2016-10-03       Impact factor: 4.430

3.  Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer.

Authors:  Kexun Zhou; Xuyu Gu; Huaicheng Tan; Ting Yu; Chunhua Liu; Zhenyu Ding; Jiyan Liu; Huashan Shi
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.